100 ହ 90 80 70 60 55.0 50 48 0 4 70 45.81 40 3 3868 30 20 18.6 10 3, 2 0 2027-12-37 | 2020-12-37 1 2021-06-30 1 202-06-30 ' 2022-12-37 V +-06-30 1 3-12-37 " 3-06-30 1 2n~ ） 制图数据来自恒生聚源数据库 市净率(LF)历史分位(%) 中证智能财讯迪瑞医疗（300396）1月30日晚间披露2025年度业绩预告，预计2025年归母净利润亏损1.8亿元至3.5亿元，上年同期盈利1.42亿元；扣非净利润 亏损1.85亿元至3.6亿元，上年同期盈利1.34亿元。以最新收盘价计算，市净率（LF）约1.91倍，市销率（TTM）约7.1倍。 以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示： 近年来市盈率变化情况（倍） 120 超 90 60 30 32d09 == 26:85 -- 27x26 23x29 20 47:44 0 -30 2020-12-37 2021-12-37 2021-06-30 ' 022-06-30 3-06-30 2 ...

Core Viewpoint - The company is expected to report a net loss attributable to shareholders of between 140 million to 196 million yuan for the year 2025, an improvement from a loss of 270 million yuan in the previous year [4] Financial Performance - The forecasted net profit loss for 2025 is between 140 million to 196 million yuan, while the non-recurring net profit loss is expected to be between 120 million to 176 million yuan, compared to a loss of 266 million yuan in the previous year [4] - The company's price-to-book ratio (LF) is approximately 36.71 times, and the price-to-sales ratio (TTM) is about 50.34 times based on the latest closing price [4] Business Operations - The company's main business segments include intelligent manufacturing and comprehensive information solutions [14] - The performance decline is attributed to underperformance of subsidiaries leading to goodwill impairment, and losses from equity investments due to poor industry conditions [14] - The company is actively managing receivables and has faced extended collection periods and increased credit risk due to intensified competition and cash flow pressures in certain client industries [14] Strategic Developments - The company has introduced a strategic investor, China CITIC Financial Asset Management Co., Ltd., to optimize its debt financing structure and reduce financing costs, which has positively impacted the reduction of interest expenses compared to the previous year [14] Non-Recurring Items - It is anticipated that non-recurring gains and losses will impact the net profit attributable to shareholders by approximately 20 million yuan, primarily due to fair value losses from associated companies [15]

中证智能财讯四川美丰（000731）1月30日晚间披露2025年度业绩预告，预计2025年归母净利润亏损9800万元至1.29亿元，上年同期盈利2.72亿元；扣非净利 润亏损1.32亿元至1.68亿元，上年同期盈利2.02亿元；基本每股收益-0.18元/股至-0.23元/股。以最新收盘价计算，市净率（LF）约0.98倍，市销率（TTM）约 0.89倍。 以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示： 近年来市盈率变化情况（倍） 100 砸 80 60a04 60 40 21692 20 4594 13.07 -9.94 7.66 7.32 ୧ 88 0 -20 -40 2021-06-30 2021-12-37 ' 2020-12-37 2022-12-37 2022-06-30 3-06-30 3-12-37 4-06-31 2n- -○- 公司 -○- 行业均值 100 96.01 ହ 90 80 70 60 50 47663 40 30 27a34 21 20 1 165 10 423 5.09 0 0.8 2027-12-37 | 2020-12-37 1 2021-06-30 ' ...

上市公司可持续发展信息披露新增参考指南。 继去年指导沪深北证券交易所发布上市公司可持续发展报告首批编制指南（包括"总体要求与披露框 架""应对气候变化"）后，1月30日，证监会指导沪深北证券交易所发布"污染物排放""能源利用""水资 源利用"三个环境议题披露指南。针对相关风险和机遇的识别与评估、核算流程与方法、披露要点等重 点难点问题提供细化指导，推动上市公司提升可持续发展意识、促进规范披露。 2024年以来，证监会指导沪深北交易所发布上市公司可持续发展报告指引和上市公司可持续发展报告编 制指南，健全上市公司可持续发展披露规则体系。相关规则出台既提升了企业可持续发展意识，也帮助 企业明确了披露要点，A股上市公司ESG国际评级明显提升。 中国证券报记者了解到，后续相关部门将结合其他重要议题实践情况，加快制定相关议题编报指南，持 续丰富完善指南内容；加强市场培训，为上市公司披露可持续发展信息提供具体指导；支持推进ESG评 级、指数开发等工作，推动构建良好的可持续发展投资生态。 新设三个环境议题指南 不增加额外强制披露要求 本次发布的指南，新增污染物排放、能源利用、水资源利用三个章节。 一方面，详细解释相关议题的常 ...

Group 1 - The company expects a net loss attributable to shareholders of 250 million to 500 million yuan for the year 2025, compared to a loss of 470 million yuan in the same period last year [2] - The company's non-recurring net profit is projected to be a loss of 280 million to 560 million yuan, with the previous year's loss being 462 million yuan [2] - The basic earnings per share are estimated to be between -0.1451 yuan and -0.2901 yuan [2] Group 2 - The company's main business includes landscape engineering construction, landscape design, architectural design, seedling planting production, and landscape maintenance services, providing integrated services to clients [11] - The company's revenue and gross profit have declined due to intensified market competition and extended project settlement cycles [11] - The company plans to recognize impairment losses on accounts receivable, contract assets, and long-term receivables based on cautious principles, with specific amounts to be determined after audit [11]

Company Performance - The company, Tenglong Co., Ltd. (603158), expects to achieve operating revenue of 3.965 billion to 4.382 billion yuan in 2025, representing a year-on-year growth of 3.97% to 14.92% [4] - The net profit attributable to shareholders is projected to be between 46 million and 69 million yuan, indicating a significant decline of 72.38% to 81.59% year-on-year [4] - The expected net profit after deducting non-recurring gains and losses is estimated to be between 28.8 million and 51.8 million yuan, reflecting a decrease of 72.21% to 84.55% year-on-year [4] Valuation Metrics - As of January 30, the company's price-to-earnings (P/E) ratio (TTM) is approximately between 73.69 and 110.53 times, while the price-to-book (P/B) ratio (LF) is about 2.19 times, and the price-to-sales (P/S) ratio (TTM) is around 1.22 times [4] Business Overview - The company specializes in the research, development, production, and sales of automotive thermal management components and is recognized as a leading domestic automotive parts manufacturer [13] - The performance fluctuation is attributed to steady growth in the main business, increased industry competition, and the ramp-up period of new projects in Poland and Anhui, leading to higher fixed asset depreciation and a slight decline in gross margin [13] - The company has implemented various measures to improve profitability, including cost reduction in the supply chain and enhancing operational efficiency, which are gradually showing results [13]

1月30日，证监会就《公开募集证券投资基金信息披露内容与格式准则第2号—定期报告的内容与格式》 向社会公开征求意见，基金业协会同步就《证券投资基金信息披露XBRL模板》征求行业意见。 本次修订后，信息披露规则体系更加简明，信披内容更加突出"以投资者为本"的理念，监管导向上更加 偏重提升投资行为稳定性。 证监会将在本次XBRL模板中，要求基金管理人在年报中披露报告期内相关产品的股票换手率数据，强 化投资行为稳定性的信息揭示，督促基金管理人、基金经理形成更加审慎、理性的投资观念，纠治过于 激进的投资行为。 基金业协会将在本次XBRL模板中，要求管理人在年报、半年报、季报中新增产品过去7、10年中长期 业绩，不再披露过去1个月的业绩，引导行业更加注重"长期投资、价值投资"理念。 《准则》共3章36条，主要修订内容如下：一是对年度报告、半年度报告和季度报告中相同或相近的披 露事项进行整合。二是根据年度报告、半年度报告和季度报告不同功能定位，提出针对性、个性化披露 要求。三是根据上位法规要求及行业实践，借鉴境外成熟市场经验，简化、调整部分信息披露要求。四 是授权基金业协会根据《准则》及信息披露活动制订可拓展商业报告语言 ...

以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示： 资料显示，公司主营POCT试剂及仪器。 中证智能财讯安旭生物（688075）1月30日晚间披露2025年度业绩预告，预计2025年归母净利润7100万元至8500万元，同比下降55.8%-63.08%；扣非净利润 预计1300万元-1560万元，同比下降58.84%-65.7%。以1月30日收盘价计算，安旭生物目前市盈率（TTM）约为60.16倍-72.03倍，市净率（LF）约0.99倍，市 销率（TTM）约11.05倍。 此外，美国政府加征关税使得部分区域市场订单减少，公司承担部分关税导致营业成本上升，加上汇率波动引起汇兑损失、利息收入降低及资产折旧摊销等 多方面原因导致利润同比下滑。 指标注解： 据公告，公司业绩变动原因为， 报告期内，公司主营业务保持稳健发展，为巩固在产业领域内的长期竞争优势，公司保持原有几大技术平台的先进性之 外，持续加大对新技术平台的战略性投入，同时国内外市场及注册证书等拓展，海外分子公司的布局致使费用增加。 市盈率=总市值/净利润。当公司亏损时市盈率为负，此时用市盈率估值没有实际意义，往往用市净率或市销率做参考。 市 ...

Core Viewpoint - The company, Ruiqi Co., Ltd. (300126), has announced a significant expected loss for the year 2025, projecting a net loss attributable to shareholders between 46.54 million and 62.37 million yuan, compared to a loss of 19.26 million yuan in the same period last year [4]. Financial Performance - The expected net profit loss for 2025 is between 46.54 million yuan and 62.37 million yuan, with a previous year's loss of 19.26 million yuan [4]. - The expected non-recurring net profit loss ranges from 65.74 million yuan to 81.57 million yuan, compared to a loss of 40.88 million yuan in the previous year [4]. - The company's price-to-book ratio (LF) is approximately 2.59 times, and the price-to-sales ratio (TTM) is about 5.76 times based on the latest closing price [4]. Reasons for Performance Change - The significant changes in operating performance are primarily attributed to rising raw material prices, increased operating costs, and higher expenses, leading to a decline in overall gross profit margin [12]. - The impact of non-recurring gains and losses on net profit is approximately 19.19 million yuan, compared to 21.62 million yuan in the previous year [12]. Historical Financial Trends - Historical data indicates a trend of increasing losses over the years, with the projected net profit and non-recurring net profit for 2025 showing a continued decline [14]. - The year-on-year growth rates for net profit and non-recurring net profit have shown significant negative changes, indicating a challenging financial environment for the company [14].

中证智能财讯万达信息（300168）1月30日晚间披露2025年度业绩预告，预计2025年实现营业收入19.5亿元至21.5亿元；归母净利润亏损5.25亿元至6亿元， 上年同期亏损6.86亿元；扣非净利润亏损5.9亿元至6.85亿元，上年同期亏损7.71亿元。以最新收盘价计算，市净率（LF）约7.89倍，市销率（TTM）约4.74 倍。 以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示： 资料显示，公司主要业务涵盖数智医卫、数智政务、数智金融三大领域，以ICT信息科技创新为公司整体软件解决方案基石，向健康管理、智慧城市方向延 伸发展。 据公告，1.报告期内，公司实现减亏，归属于上市公司股东的净利润同比提升约12%–23%。2.公司通过持续推进降本增效举措，使得人工成本及费用总体支 出规模同比下降，运营效率提升，但营业收入仍无法覆盖运营成本及固定费用开支，导致公司仍处于亏损状态。3.部分资产存在减值迹象，资产组未来经济 利益流入低于预期，部分存货成本高于其可变现净值，经初步评估商誉及存货减值规模约0.7–1.0亿元，较上年同期1.5亿元下降约33%–53%。4.报告期内， 公司预计实现非经常性损益 ...